Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)

NCT01733134 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor decided to quit funding before any enrollments

Conditions

Acute Heart Failure

Interventions

DRUG: Tolvaptan
DRUG: placebo

Sponsor

Maisel, Alan, M.D.

Collaborators

[object Object]
[object Object]